AstraZeneca’s Soriot Keeps His Options Open When It Comes To Sanofi
This article was originally published in The Pink Sheet Daily
Executive Summary
CEO Soriot declined to say whether or not he is considering taking over the top spot at rival Sanofi during a media briefing, doing nothing to end speculation he might be a contender to succeed Viehbacher.